A retracted study on the safety of blood pressure medications in patients with COVID-19 continues to be cited nearly a year later, new research shows. The study in question, published on May 1, 2020 in the New England Journal of Medicine (NEJM), showed no increased risk for in-hospital death with the use of angiotensin-converting-enzyme (ACE) inhibitors